Related Experiment Video
Updated: May 2, 2026
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Synthetic lethal screens as a means to understand and treat MYC-driven cancers
Silvia Cermelli1, In Sock Jang, Brady Bernard
1Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109.
Abstract:
Although therapeutics against MYC could potentially be used against a wide range of human cancers, MYC-targeted therapies have proven difficult to develop. The convergence of breakthroughs in human genomics and in gene silencing using RNA interference (RNAi) have recently allowed functional interrogation of the genome and systematic identification of synthetic lethal interactions with hyperactive MYC. Here, we focus on the pathways that have emerged through RNAi screens and present evidence that a subset of genes showing synthetic lethality with MYC are significantly interconnected and linked to chromatin and transcriptional processes, as well as to DNA repair and cell cycle checkpoints. Other synthetic lethal interactions with MYC point to novel pathways and potentially broaden the repertoire of targeted therapies. The elucidation of MYC synthetic lethal interactions is still in its infancy, and how these interactions may be influenced by tissue-specific programs and by concurrent genetic change will require further investigation. Nevertheless, we predict that these studies may lead the way to novel therapeutic approaches and new insights into the role of MYC in cancer.
Insights
Researchers are identifying new ways to target MYC in cancer. RNA interference screens reveal synthetic lethal interactions, uncovering potential new therapeutic strategies for MYC-driven cancers.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- MYC is a key driver in many human cancers, but developing targeted therapies has been challenging.
- Advances in genomics and RNA interference (RNAi) enable systematic identification of synthetic lethal interactions with MYC.
- Understanding these interactions is crucial for developing novel cancer treatments.
Purpose of the Study:
- To identify and analyze synthetic lethal interactions with hyperactive MYC using RNAi screens.
- To explore the pathways and biological processes associated with these MYC synthetic lethal interactions.
- To assess the potential of these interactions for developing new MYC-targeted cancer therapies.
Main Methods:
- Utilized RNA interference (RNAi) screening to functionally interrogate the genome.
- Systematically identified genes exhibiting synthetic lethality with hyperactive MYC.
- Analyzed the interconnectedness of identified genes and their link to cellular processes.
Main Results:
- A subset of genes showing synthetic lethality with MYC are interconnected and involved in chromatin, transcription, DNA repair, and cell cycle checkpoints.
- Discovered novel pathways through other synthetic lethal interactions with MYC.
- These findings suggest a broader repertoire of potential targeted therapies.
Conclusions:
- MYC synthetic lethal interactions are a promising area for novel cancer therapeutic development.
- Further research is needed to understand tissue-specific influences and concurrent genetic changes.
- These studies offer new insights into MYC's role in cancer and potential treatment strategies.
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...